Merck gets EU panel nod for Ebola vaccine

(Reuters) - Merck & Co's vaccine for the Ebola virus received recommendation of approval from a panel of the European drugs regulator on Friday, taking it a step closer in becoming the first vaccine to be officially sanctioned for the rare and deadly disease. Read Full Story